1/n) Excited to share our work! @CBCjournal The ?: How effective is ovarian suppression (OFS) to maintain long-term estrogen suppression for premenopausal 🚺 with breast cancer undergoing treatment with endocrine therapy (ET)? Our findings 👇🏻 #bcsm https://t.co/D5ZNkuJxUk

Achieving your goals is not about being more efficient in your tasks. It's about being more selective in your commitments. More free time in the future is an illusion. You won't be less busy—you'll just be busy with new priorities. If it's not an enthusiastic yes, it's a no.

Deadlines extended: Due dates for two @SWOG research funding opportunities - the Coltman Fellowship and Career Engagement Award - have been extended for 2023. Applications now accepted through September 1 #SWOGonc https://t.co/fRN6nMYXCZ

Congrats to all 51 faculty members appointed to professorships in 2022, including Drs. William Chey, Mona Doshi, MeiLan Han, Peter Higgins, Jeffrey Kullgren, Sami Malek, Goutham Narla, Nithya Ramnath, Nicole Seiberlich, Ulka Vaishampayan, Jun Wu & Ray Zuo! https://t.co/USYwP0fik8

The S2010 team is developing a risk prediction model to try to identify which patients are most likely to benefit from adding active symptom monitoring to patient education. https://t.co/ulwqaN4mwP. Biostatisticians: @DrJoeUnger @riharv @FredHutch @OncoAlert #breastcancer

S2010 tests patient education w/wo active symptom monitoring in patients w stage 1-3 HR+ BC on #endocrinetherapy. It compares endocrine therapy adherence between the 2 arms and symptoms between the arms. https://t.co/ulwqaN4mwP Co-PI: @DrDawnHershman @ColumbiaCancer #BCSM

Side effects from #endocrinetherapy for #breastcancer lead some women to stop their therapy early. S2010 tests whether asking about side effects between doctor visits will help more women stay on therapy. To learn more, visit https://t.co/HxsGMKpegx. Or call 1-800-4-CANCER. #BCSM

Spring 2023 @SWOG group meeting is May 10-13, SF Hyatt Regency & online. Registration opens March 7 at https://t.co/aMIxq7tu6g! Plenary theme: oncology research across borders. Special symposia: microbiome, reducing structural barriers to trials to ensure equity, & more. #SWOGonc

Thanks to the NCI for funding our new trial!

Are women more likely to keep taking hormone therapy for #breastcancer when their doctor monitors side effects in between clinic visits? #Clinicaltrial S2010 asks this question. To learn more, visit https://t.co/HxsGMKpegx. Or call 1-800-4-CANCER. #BCSM

Thank you for highlighting #SWOG S1200 and the beneficial long term effects of acupuncture for AI arthralgias. Now we just need to get insurance to cover the costs… @SWOGonc

Faculty at the @SWOG Latin America Initiative clinical trials training course in Montevideo, Uruguay. Heard 8 great clinical cancer research proposals from enthusiastic trainees today. Congrats on a successful event!

Walk through the city’s 1.45M trees, eat one of the world’s best sandwiches, and attend a nationally-ranked medical school program @umich. Life in Ann Arbor is pretty great. #WhyUMichMedicine #GoBlueMed

We are recruiting an Assistant Prof to join our Sarcoma Med Onc Team @UMRogelCancer! Clinical trials focus is preferred. @UMich is highly collaborative with multi-D care and team science including a new SPORE. Please apply at https://t.co/g21FDYneid. @RashmiChughMD @cvangelesMD

We're recruiting an Assistant Prof to join our GU Med Onc Team @UMRogelCancer! Clinical trials focus is preferred. @UMich is highly collaborative with many GU team science initiatives & multi-D care. Apply: https://t.co/Gr9VWrl5PT or email me. Please RT! @PCF_Science @ThePCCTC

Biomarkers for Systemic Therapy in Metastatic #breastcancer : ASCO Guideline Update Q and A https://t.co/ZGvpuAfXvC @JCOOP_ASCO @ASCO @EthicsdoctorP @OncoAlert

Great resource for those considering applying for a @ConquerCancerFd Young Investigator Award—or any grant for that matter— Please consider joining

Are you a proud Conquer Cancer grant recipient like @GMRodriguez_MD, @AnaVManana, @DrSteveMartin, @dradityabardia, @SusanScottMD, @BGriebMD, @jakeyoung11, @JieDengMDPhD and others? RT this badge and spread the word – YIA applications are open! https://t.co/ZHm1j9SDbd

The latest ASCO guideline update on #biomarkers in metastatic #breastcancer supports PIK3CA, BRCA1/2, & PD-L1 testing. Expert Panel co-chairs Drs. @AngieDemichele & @lynnhenrymd discuss the guideline's 11 recommendations. https://t.co/xahce63GwO #ASCODailyNews #bcsm

ASCO Pulse Check📝: If you treat patients with cancer, please take 2 minutes to complete this survey on clinician contentment https://t.co/ZV9nXWZrhg #ASCO22